Sanofi SNY announced that the FDA has granted a Breakthrough Therapy designation to its investigational oral BTK inhibitor, ...

The investigational oral HER2-specific tyrosine kinase inhibitor would address an unmet need in non–small cell lung cancer.

Deep brain stimulation of the lateral hypothalamus improves walking and promotes recovery in patients with spinal cord injury ...

French drug major Sanofi (SNY) announced Friday that the U.S. Food and Drug Administration has granted Breakthrough Therapy ...

Tolebrutinib designated Breakthrough Therapy by the FDA for non-relapsing secondary progressive multiple sclerosisDesignation is based on ...

A new study reveals how a single species of bacteria can sustain a diverse community of phage species, with implications for ...

Vir Biotechnology (NASDAQ:VIR) said its drugs tobevibart and elebsiran have received FDA Breakthrough Therapy designation for the treatment of chronic hepatitis delta. The drugs have also received ...

A pair of studies presented at the 2024 American Society of Hematology (ASH) Annual Meeting & Exposition highlight continuing ...

Mesenchymal stem cells, or MSCs, have been an area of interest for decades and have shown efficacy in treating inflammation-driven diseases beyond heart failure, including chronic lower-back pain.

Epigenic, Immunocan have officially moved into Bayer Co.Lab, and AccurEdit Therapeutics will join early next month. Photo: Courtesy of Bayer Co.Lab Epigenic, Immunocan have officially moved into Bayer ...

At a time when fundamental questions are being posed about medical science, writes Jennifer Handt, let us not forget the beauty of it, the existential poetry and shared humanity that drives us toward ...

Type 1 diabetes, once known as juvenile or insulin-dependent diabetes, is a chronic health condition. In people with this ...